Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Receivables - Accured: 2024

Historic Receivables - Accured for Kura Oncology (KURA) over the last 1 years, with Dec 2024 value amounting to $3.3 million.

  • Kura Oncology's Receivables - Accured rose 73.68% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 73.68%. This contributed to the annual value of $3.3 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Kura Oncology's Receivables - Accured is $3.3 million.
  • Kura Oncology's Receivables - Accured's 5-year high stood at $3.3 million during FY2024, with a 5-year trough of $3.3 million in FY2024.
  • In the last 1 years, Kura Oncology's Receivables - Accured had a median value of $3.3 million in 2024 and averaged $3.3 million.